Reckitt Benckiser Group plc (LON:RKT - Get Free Report)'s stock price reached a new 52-week high during mid-day trading on Wednesday following insider buying activity. The stock traded as high as GBX 5,722 ($75.95) and last traded at GBX 5,652 ($75.02), with a volume of 1429151 shares changing hands. The stock had previously closed at GBX 5,624 ($74.65).
Specifically, insider Margherita Della purchased 267 shares of Reckitt Benckiser Group stock in a transaction dated Tuesday, July 29th. The shares were acquired at an average price of GBX 5,649 ($74.98) per share, with a total value of £15,082.83 ($20,019.68). Also, insider Jeremy Darroch bought 1,652 shares of Reckitt Benckiser Group stock in a transaction that occurred on Tuesday, July 29th. The stock was purchased at an average cost of GBX 5,649 ($74.98) per share, for a total transaction of £93,321.48 ($123,867.11).
Wall Street Analysts Forecast Growth
Several brokerages recently weighed in on RKT. Royal Bank Of Canada raised their target price on shares of Reckitt Benckiser Group from GBX 5,700 ($75.66) to GBX 6,000 ($79.64) and gave the company an "outperform" rating in a report on Thursday, July 24th. Deutsche Bank Aktiengesellschaft reaffirmed a "hold" rating and issued a GBX 5,300 ($70.35) target price on shares of Reckitt Benckiser Group in a report on Monday, July 21st.
View Our Latest Stock Analysis on RKT
Reckitt Benckiser Group Price Performance
The company has a debt-to-equity ratio of 110.26, a current ratio of 0.69 and a quick ratio of 0.46. The firm has a market capitalization of £38.37 billion, a price-to-earnings ratio of 25.73, a PEG ratio of 1.10 and a beta of 0.09. The company's 50-day moving average is GBX 5,122.88 and its 200-day moving average is GBX 5,086.87.
Reckitt Benckiser Group (LON:RKT - Get Free Report) last issued its earnings results on Thursday, July 24th. The company reported GBX 141.20 ($1.87) earnings per share (EPS) for the quarter. Reckitt Benckiser Group had a return on equity of 18.70% and a net margin of 10.78%. On average, research analysts expect that Reckitt Benckiser Group plc will post 331.2110727 earnings per share for the current year.
Reckitt Benckiser Group Company Profile
(
Get Free Report)
At Reckitt, we protect, heal and nurture. We are the company behind some of the world's best known and most trusted Health and Hygiene consumer brands.
Delivering for a cleaner, healthier world requires strong brands with a global footprint. From Dettol, Lysol, Durex, Finish, Harpic and Vanish, Mucinex, Nurofen, Gaviscon, Veet and Strepsils, consumers love and rely on our brands to care for their families, as they have done for over 200 years.
We use our scientific expertise and deep human understanding to develop solutions to help people improve their lives – that is why over 30 million Reckitt products are sold each day worldwide.
At Reckitt, we're all making a real difference to people all over the world, every day.
Read More
Before you consider Reckitt Benckiser Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Reckitt Benckiser Group wasn't on the list.
While Reckitt Benckiser Group currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.